Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Feb 2005

Gu Jian, Zhao Hua, Dinney Colin P, Zhu Yong, Leibovici Dan, Bermejo Carlos E, Grossman H Barton, Wu Xifeng

Abstract excerpt

PURPOSE: Interindividual differences in DNA repair capacity not only modify individual susceptibility to carcinogenesis, but also affect individual response to cancer treatment. Nucleotide excision repair (NER) is one of the major DNA repair pathways in mammalian cells involved in the removal of a wide variety of DNA lesions. Polymorphisms in NER genes may influence DNA repair capacity and affect clinical outcome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BCG Vaccine
Share to DNA Helicases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Repair Enzymes

Share to Multivariate Analysis

Share to Neoplasm Recurrence, Local

Share to Poly-ADP-Ribose Binding Proteins

Share to Urinary Bladder Neoplasms

Share to Xeroderma Pigmentosum Group A Protein

Source

Identifiers

PMID: 15746040
DOI: 10.1158/1078-0432.CCR-04-1101

Genes

ERCC6
XPA
XPC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.PMID 15746040Read ↗

Impact of nucleotide excision repair ERCC2 and base excision repair APEX1 genes polymorphism and its association with recurrence after adjuvant BCG immunotherapy in bladder cancer patients of North India.Semantic proximity Read ↗

E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer.Semantic proximity Read ↗

The Role of Vitamin D Receptor Polymorphisms in Predicting the Response to Therapy for Nonmuscle Invasive Bladder Carcinoma.Semantic proximity Read ↗

Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study.Semantic proximity Read ↗

Genetic Variations in Glutathione Pathway Genes Predict Cancer Recurrence in Patients Treated with Transurethral Resection and Bacillus Calmette-Guerin Instillation for Non-muscle Invasive Bladder Cancer.Semantic proximity Read ↗

Meta-analysis reveals no significant association between ERCC6 polymorphisms and bladder cancer risk.Semantic proximity Read ↗

Bladder cancer: genetic variants modify risks of recurrence and survival.Semantic proximity Read ↗

Genetic variation in the nucleotide excision repair pathway and bladder cancer risk.Semantic proximity Read ↗

The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence.Semantic proximity Read ↗

Nucleotide excision repair gene polymorphisms may predict acute toxicity in patients treated with chemoradiotherapy for bladder cancer.Semantic proximity Read ↗

Interaction between polymorphisms of DNA repair genes significantly modulated bladder cancer risk.Semantic proximity Read ↗

Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.